Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 4791-4796, October 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanisch, F-G.
Right arrow Articles by Borchard, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanisch, F-G.
Right arrow Articles by Borchard, F.

Monoclonal Antibody 2B5 Defines a Truncated O-Glycan, GlcNAcß1-3Galß1-4GlcNAcß1-6 (GalNAc), on Mucins from Deep Gastric and Duodenal Glands as Well as Metaplasia and Neoplasia of Gastric Differentiation

F-G. Hanisch1, U. Koldovsky and F. Borchard

Institut für Immunbiologie, Universitätsklinik Köln Kerpener Strasse 15, D-50937 Köln-41 [F-G. H.], and Frauenklinik [U. K.] and Zentrum für Pathologie [F. B.], Heinrich Heine Universität Düsseldorf, Moorenstrasse 5, D-40225 Düsseldorf-1, Germany

Monoclonal antibody (MAb) 2B5 previously generated in BALB/c mice using gastric mucosa of the corpus as immunogen was characterized with regard to its binding epitope. Binding assays on structurally defined neoglycolipids from mucin glycans revealed that MAb 2B5 recognizes a carbohydrate epitope on a neutral O-glycan sequence from gastric mucins. This oligosaccharide chain has been characterized by mass spectrometry and methylation analysis and sequential exoglycosidase treatment of the derived neoglycolipid as GlcNAcß1-3Galß1-4GlcNAcß1-6OY (where 6OY corresponds to the GalNAc-ol fragment--O-(CH2)2 conjugated to dipalmitoylphosphatidylethanolamine). The selective binding of MAb 2B5 to mucus from deep gastric and duodenal glands, to gastric metaplasia or neoplasia with gastric differentiation may imply that mucin glycosylation in the respective cells is incomplete resulting in the accumulation of truncated blood group precursor chains. MAb 2B5 is the first monoclonal antibody which defines an epitope on M2-type antigens and may substitute, accordingly, for the inconvenient "paradoxical concanavalin A-horseradish peroxidase method" in histochemistry.

1 To whom requests for reprints should be addressed.

Received 7/21/93. Accepted 9/ 2/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Meichenin, J. Rocher, O. Galanina, N. Bovin, N. Nifant’ev, A. Sherman, E. Cassagnau, M. F. Heymann, J. Bara, R. H. Fraser, et al.
Tk, a New Colon Tumor-associated Antigen Resulting from Altered O-Glycosylation
Cancer Res., October 1, 2000; 60(19): 5499 - 5507.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
N. Nakamura, H. Ota, T. Katsuyama, T. Akamatsu, K. Ishihara, M. Kurihara, and K. Hotta
Histochemical Reactivity of Normal, Metaplastic, and Neoplastic Tissues to {alpha}-Linked N-Acetylglucosamine Residue-specific Monoclonal Antibody HIK1083
J. Histochem. Cytochem., July 1, 1998; 46(7): 793 - 802.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.